This compares to our previous estimate of $85,000,000 As we look forward to 2022, we would expect our net operating loss in corporate to be closer to $90,000,000 more in line with historical trends. Turning to the holding company liquidity, including the net proceeds from the sale of preneed in August, We ended the Q3 with over $1,300,000,000 well above our current minimum target level. In the 3rd quarter, dividends from Operating segments totaled $127,000,000 In addition to our quarterly corporate and interest expenses, We also had outflows from 3 main items, dollars 323,000,000 of share repurchases, dollars 39,000,000 in common stock dividends and $11,000,000 mainly related to Assurant Ventures Investments. In addition to completing our 2019 Investor Day objective Of returning $1,350,000,000 to shareholders from 2019 through 2021, We have also completed roughly 1 quarter of our objective to return $900,000,000 in global preneed sale proceeds through share repurchases. For the year overall, we continue to expect dividends to approximate segment earnings, Subject to the growth of the businesses, rating agency and regulatory capital requirements and Investment Portfolio Performance.